Control lymphocyte subsets: can one country's values serve for another's?
- PMID: 25171870
- PMCID: PMC4150016
- DOI: 10.1016/j.jaci.2014.06.030
Control lymphocyte subsets: can one country's values serve for another's?
Abstract
Lymphocyte subsets can be affected by host and environmental factors, yet direct comparisons of their patterns across continents are lacking. This work compares proportions and counts of lymphocyte subsets between healthy children from Thailand, Malawi and the USA. We analyzed subsets of 1,399 healthy children aged between 0 and 15 years: 281 Thai, 397 Malawian and 721American children. Existing data for five subsets were available for all three cohorts (Total T, CD4+ T, CD8+ T, natural killer (NK) and B cells), with data for another six subsets from the Thai and American cohorts (naïve, memory and activated CD4+ and CD8+ T cells). Cellular patterns between cohorts differed mainly in children under two years. Compared to American children, Thai children had higher median numbers of total T cells, CD8+ T cells and NK cells while Malawian children under 18 months, on average, had more CD8+ T cells and B cells. Both Thai and Malawian children had lower median CD4+ T cell percentages and CD4/CD8 ratios than American children. Thai children had more memory and activated CD8+ T cells than American children. Approximately one-fifth of Thai and Malawian HIV-uninfected healthy children aged 0-3 years met WHO-defined CD4+ count criteria for immune-deficiency in HIV-infected children. Healthy children from Thailand, Malawi and the USA have differences in lymphocyte subsets that are likely to be due to differences in ethnicity, exposure to infectious diseases and environmental factors. These results indicate the need for country-specific reference ranges for diagnosis and management of immunologic disorders.
Figures

References
-
- Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112:973–80. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI94029/AI/NIAID NIH HHS/United States
- U01 AI068632/AI/NIAID NIH HHS/United States
- M01 RR000188/RR/NCRR NIH HHS/United States
- M01 RR-00188/RR/NCRR NIH HHS/United States
- U01 AI027551/AI/NIAID NIH HHS/United States
- 101113/WT_/Wellcome Trust/United Kingdom
- U01 AI041110/AI/NIAID NIH HHS/United States
- R01AI075408-0/AI/NIAID NIH HHS/United States
- R01 AI075408/AI/NIAID NIH HHS/United States
- U01 AI41110/AI/NIAID NIH HHS/United States
- U01AI27551/AI/NIAID NIH HHS/United States
- U01 AI068616/AI/NIAID NIH HHS/United States
- P30 AI036211/AI/NIAID NIH HHS/United States
- UM1 AI068616/AI/NIAID NIH HHS/United States
- UM1 AI069536/AI/NIAID NIH HHS/United States
- P30 AI36211/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous